Through the first nine months of 2025, the company generated $422 million in revenue -- representing an increase of 39% year ...

Rocket Lab (RKLB)’s stock surged 45%, driven not only by a robust 10% increase in revenue but also by a significant 36% ...

Shares of Abbott Laboratories plunged 10.04% to $108.61 Thursday, on what proved to be an all-around great trading session ...

Discover the catalysts, execution milestones, and defense-driven growth trends that could determine whether Rocket Lab ...

Rocket Lab looks overvalued despite Neutron/defense catalysts. Click here for more on the RKLB stock prospects.

As of Friday, January 09, Rocket Lab Corporation’s RKLB share price has surged by 5.63%, which has investors questioning if ...

Rocket Lab completes its first 2026 launch, deploying two satellites for Open Cosmos. Electron rocket proves reliable and ...

Rocket Lab USA (NASDAQ:RKLB) shares jumped about 6% on Friday after Morgan Stanley upgraded the stock from Equalweight to ...

Rocket Lab’s stock price already reflects the impact of major recent milestones and renewed enthusiasm for the space sector, ...

I know, I know. I've spent the last few months arguing that Rocket Lab -- while a superb space business and a leader in both high-tech rocketry and satellite development -- is also a very loftily ...

Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...

Abbott's Medical Devices segment, especially CGM, continues to deliver robust double-digit growth, offsetting Nutrition ...